This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Amneal Pharmaceuticals LLC, Megafine Pharma (P) Ltd.. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013-2015
Title: Sharad Subhash Ippar: Innovator in Pharmaceutical Chemistry
Introduction
Sharad Subhash Ippar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of complex compounds. With a total of 2 patents to his name, Ippar's work showcases his expertise and innovative approach to drug development.
Latest Patents
Ippar's latest patents include a method for the preparation of Cinacalcet and its intermediates and impurities. This method involves treating (R)-1-naphthyl ethylamine with an aromatic aldehyde to form a derivative, which is further processed to obtain an iminium salt. The final step involves hydrolysis to yield the Cinacalcet free base. This innovative approach highlights Ippar's commitment to advancing pharmaceutical methodologies.
Career Highlights
Throughout his career, Sharad Subhash Ippar has worked with prominent companies in the pharmaceutical industry. Notable among these are Amneal Pharmaceuticals LLC and Megafine Pharma Pvt. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various projects in drug formulation and development.
Collaborations
Ippar has collaborated with several professionals in his field, including Vijayavitthal Thippannachar Mathad and Navnath Chintaman Niphade. These collaborations have enriched his work and fostered a spirit of innovation in pharmaceutical research.
Conclusion
Sharad Subhash Ippar is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative methods and collaborations reflect his dedication to advancing the field. Ippar's work continues to inspire future innovations in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile